These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1800465)

  • 1. Spiperone: a receptor ligand and/or a granular uptake tracer?
    Huguet F; Chalon S; Guilloteau D; Besnard JC
    Int J Rad Appl Instrum B; 1991; 18(8):901. PubMed ID: 1800465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiperone: evidence for uptake into secretory granules.
    Dannies PS; Rudnick MS; Fishkes H; Rudnick G
    Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1867-70. PubMed ID: 6584920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding site of salsolinol: its properties in different regions of the brain and the pituitary gland of the rat.
    Homicskó KG; Kertész I; Radnai B; Tóth BE; Tóth G; Fülöp F; Fekete MI; Nagy GM
    Neurochem Int; 2003 Jan; 42(1):19-26. PubMed ID: 12441164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
    Chugani DC; Ackermann RF; Phelps ME
    J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland.
    Lightman SL; Ninkovic M; Hunt SP
    Neurosci Lett; 1982 Oct; 32(2):99-102. PubMed ID: 7145239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3H-spiperone labels sigma receptors, not dopamine D2 receptors, in rat and human lymphocytes.
    Coccini T; Manzo L; Costa LG
    Immunopharmacology; 1991; 22(2):93-105. PubMed ID: 1662188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary and brain D2 receptor density measured in vitro and in vivo in EEDQ treated male rats.
    Ekman A; Eriksson E
    Life Sci; 1991; 48(4):321-31. PubMed ID: 1824955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrabenazine has properties of a dopamine receptor antagonist.
    Login IS; Cronin MJ; MacLeod RM
    Ann Neurol; 1982 Sep; 12(3):257-62. PubMed ID: 7137960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M; Hidaka K; Nakamura Y
    Eur J Pharmacol; 1989 Dec; 173(2-3):177-82. PubMed ID: 2576228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP; Wooten GF
    Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [125I]Spiperone is not a useful ligand for studying the CHAPS solubilized dopamine D-2 receptor from rat striatum.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1986 May; 38(5):406-8. PubMed ID: 2423678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competition by estrogens for catecholamine receptor binding in vitro.
    Paden CM; McEwen BS; Fishman J; Snyder L; DeGroff V
    J Neurochem; 1982 Aug; 39(2):512-20. PubMed ID: 7086432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperone.
    Chivers J; Jenner P; Marsden CD
    Br J Pharmacol; 1987 Mar; 90(3):467-78. PubMed ID: 2882801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum.
    Hall H; Wedel I
    Acta Pharmacol Toxicol (Copenh); 1986 May; 58(5):368-73. PubMed ID: 2943136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
    Van der Werf JF; Van het Schip F; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of brain neurotransmitter receptors in aged rats.
    Govoni S; Memo M; Saiani L; Spano PF; Trabucchi M
    Mech Ageing Dev; 1980 Jan; 12(1):39-46. PubMed ID: 6243729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.